After having successfully missed my 5th class due to the interviews in Barcelona, we turned in our class #6 to leveraged buyouts. Because my experience in this area is almost non-existent, the quality of key class takeawas is going down definitely. As we start from the fundamentals, Scott (Scott Meadow, our humble teacher) mentioned very […]

Continue reading...

The first case discussed this week was Angstrom Medica, about the company that discovered the ways to build much better medical implants. The details of the product are quite difficult to understand for the non-medical person, while the details of the industry are also difficult for non-Americans. One of the points made by the professor […]

Continue reading...

“Valuation is the exact science that always gives a specific and only answer about the value of the company”. The second thing we are most concerned about is exit. The first one is obviously management. By the way, when talking about management the following were mentioned as the traits of the successful management teams: centrality. […]

Continue reading...

Again, stemming from the private equity class readings here are some of the notes regarding valuation (by Steven Kaplan, a famous GSB finance professor). Only the things that startled me. First of all both the APV and WACC valuation methods lead to the value of the firm with debt, i.e. enterprise value. So if after […]

Continue reading...